MedCom
MedCom
Medical TopicsExpert PerspectivesAbout
MedCom
Medical Topics
Endocrinology & Hormone Health
Hypothyroidism: Symptoms, Causes, and Diagnosis

Hypothyroidism: Symptoms, Causes, and Diagnosis

10 min readOctober 5th, 2026

Advertisement

Discover more
Verified specialist directory
Continuous glucose monitoring
Health Conditions
Specialist directory access
Medical topic guides
Prediabetes reversal program

Feeling unusually tired, gaining weight, or noticing that the cold bites harder than it used to can have many explanations. One possibility that trusted medical sources discuss is hypothyroidism, also called underactive thyroid, when the thyroid gland does not make enough thyroid hormones for the body's needs. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, part of the National Institutes of Health), those hormones help control how the body uses energy and affect nearly every organ, including heart rate. Without enough hormone, many body functions slow down.

The NHS describes underactive thyroid as a common condition that can cause tiredness and weight gain and that can usually be managed with treatment. The Endocrine Society similarly notes that hypothyroidism may stem from autoimmune disease (such as Hashimoto's disease), certain medicines, or pituitary dysfunction, and that it is more common in adults and women and tends to run in families. A JAMA Patient Page frames hypothyroidism as thyroid hormone deficiency whose causes differ by setting: in the United States and other high-income, iodine-sufficient regions, Hashimoto's disease is the most common cause; worldwide, insufficient iodine remains the leading cause.

How common the condition is depends on where you look and how it is defined. NIDDK reports that nearly 5 of 100 Americans ages 12 and older have hypothyroidism, most of them mild with few obvious symptoms. JAMA materials cite a worldwide prevalence range of roughly 0.3% to 12%, depending in part on iodine status. Those figures are not interchangeable global rates; they reflect different populations and definitions and should stay separate.

This article covers symptoms, causes, blood tests, subclinical disease, when to seek care (including pregnancy and rare emergencies), and high-level levothyroxine care, without dosing tables.

Key Takeaways

  • Hypothyroidism means the thyroid does not make enough thyroid hormone; in iodine-sufficient countries such as the UK and US, Hashimoto's autoimmune thyroiditis is the main cause, while insufficient iodine remains the leading cause worldwide. Prevalence figures from NIDDK (US) and JAMA (worldwide range) are not one interchangeable global rate.
  • Subclinical hypothyroidism is high TSH with normal free T4; NICE may consider levothyroxine in sourced scenarios (including TSH ≥10 mIU/L on two occasions, or a time-limited trial under 65 with TSH <10 plus symptoms), while a BMJ Rapid Recommendation (2019) strongly recommends against treating most adults with SCH (with exclusions). Decisions are clinician-led; do not self-start thyroid hormone for borderline labs.
  • Standard first-line treatment for primary hypothyroidism is clinician-adjusted levothyroxine with blood-test monitoring; NICE does not routinely offer liothyronine or natural thyroid extract, and a Cochrane review found insufficient evidence for selenium in Hashimoto's. Dose tables and DIY pregnancy adjustments are not patient self-care.

What Hypothyroidism (Underactive Thyroid) Is

An underactive gland

The thyroid is a small butterfly-shaped gland in the front of the neck. Hypothyroidism means it does not produce and secrete enough thyroid hormones, mainly thyroxine (T4) and triiodothyronine (T3), for the body's needs. NICE guideline NG145 (Thyroid disease: assessment and management) defines hypothyroidism as inadequate production and secretion of thyroid hormones and distinguishes primary disease (problem in the thyroid gland itself) from secondary (central) disease related to the pituitary.

Why hormones matter

NIDDK explains that thyroid hormones help control energy use and affect nearly every organ. Untreated disease can lead to serious complications, including heart failure and myxedema (myxoedema) coma, a rare but life-threatening extreme (JAMA).

Mild cases and "subclinical" disease

Many people with hypothyroidism have mild disease. Some have raised thyroid-stimulating hormone (TSH) with free T4 still in the laboratory reference range, called subclinical hypothyroidism, which is defined and discussed separately below. Mild laboratory findings and vague symptoms do not automatically mean someone needs lifelong medicine; that decision belongs with a clinician.

Common Symptoms, and Why They Are Not a Diagnosis by Themselves

Symptoms often develop slowly

Trusted patient sources describe symptoms that often develop over months or years and may be easy to miss at first. Features commonly listed include:

  • Fatigue or extreme tiredness
  • Weight gain
  • Cold intolerance: feeling cold more than usual
  • Constipation
  • Dry skin, dry or thinning hair, or hair loss
  • Low mood or depression
  • Difficulty concentrating, memory problems, or "brain fog"
  • Muscle or joint pain, stiffness, or cramps
  • Heavy or irregular periods and, in some cases, fertility problems
  • Slowed heart rate
  • Hoarse or croaky voice
  • Goiter or neck enlargement in some people, especially with Hashimoto's disease; the Endocrine Society notes that enlargement can occasionally cause trouble swallowing or breathing

Overlap with other conditions

Fatigue and weight gain are common in daily life and are not necessarily thyroid-related (NIDDK). NICE notes that one symptom alone may not indicate thyroid disease and that the decision to test is clinical judgment; menopausal symptoms can also be mistaken for thyroid dysfunction. Cochrane materials on subclinical hypothyroidism similarly describe vague, non-specific features such as dry or cold skin, feeling colder, constipation, slower thinking, and poor memory, and emphasize that diagnosis rests on blood tests, not symptoms alone.

Symptoms orient a conversation with a clinician. They do not authorize self-diagnosis of hypothyroidism.

Main Causes and Who Is More Likely to Be Affected

Hashimoto's disease in iodine-sufficient countries

In iodine-sufficient settings such as the United Kingdom and the United States, the main cause of primary hypothyroidism is Hashimoto's disease (autoimmune thyroiditis): the immune system attacks the thyroid and reduces hormone production over months to years. The NHS describes Hashimoto's as the main UK cause, more often in women and often ages 30-50. The Endocrine Society calls it the most common cause of hypothyroidism in iodine-sufficient areas, including the United States, often with thyroid peroxidase (TPO) antibodies, genetic and environmental contributions, family clustering, and higher likelihood when other autoimmune disease is present. A JAMA review notes that Hashimoto's accounts for up to about 85% of primary hypothyroidism in iodine-adequate areas.

Worldwide iodine context

A JAMA Patient Page states that insufficient iodine is still the most common cause of hypothyroidism worldwide, while Hashimoto's predominates in high-income, iodine-sufficient regions. NIDDK and the NHS both note that iodine deficiency is extremely rare or rare in the United States and United Kingdom. Excess iodine, including from seaweed or high-dose supplements, can worsen autoimmune thyroid disease (NIDDK); that is not a reason to self-treat with iodine megadoses.

Other sourced causes

Trusted pages also list:

  • Thyroiditis (including subacute, postpartum, and silent forms) that may progress from a temporary high-hormone phase to underactivity
  • Surgical removal of part or all of the thyroid
  • Radioactive iodine or external radiation to the neck or chest, and treatment for overactive thyroid
  • Certain medicines: NIDDK mentions examples in heart, bipolar, and cancer treatment categories; JAMA materials name immune checkpoint inhibitors and amiodarone among medicines linked to risk
  • Congenital hypothyroidism
  • Less often, pituitary or hypothalamic (central/secondary) disorders

Advertisement

Who is at higher risk

NIDDK lists higher risk among women, people older than 60, those with prior thyroid problems, surgery, or radioactive iodine, neck or chest radiation, family history of thyroid disease, pregnancy in the past six months, and other autoimmune conditions such as vitiligo, celiac disease, Sjögren's syndrome, pernicious anemia, diabetes, rheumatoid arthritis, or lupus. The Endocrine Society and JAMA highlight similar patterns. Diabetes-related specialist context: When Should You See an Endocrinologist for Diabetes?; Type 1 vs Type 2 Diabetes: Understanding the Key Differences; Insulin Resistance: What It Is and Why It Matters. NICE discusses offering testing for type 1 diabetes and other autoimmune disease; JAMA notes targeted testing for high-risk groups.

NIDDK's pregnancy page notes that hypothyroidism in pregnancy is usually Hashimoto's (about 2-3 of 100 pregnancies) and that postpartum thyroiditis occurs in about 1 in 20 people in the first year after birth.

How Clinicians Diagnose It (TSH, Free T4, and Antibodies at a High Level)

Not symptoms alone

NIDDK is explicit: hypothyroidism cannot be diagnosed on symptoms alone. Clinicians take a history (including family autoimmune or thyroid history and recent pregnancy), may examine the neck, and use blood tests. The NHS describes a similar GP pathway: symptoms, family and autoimmune history, recent pregnancy, possible neck exam, then blood tests for TSH and thyroxine (T4), with specialist referral when needed.

What TSH and free T4 mean (high level)

  • TSH is usually the first test in primary care when pituitary disease is not suspected. A high TSH most often points toward primary hypothyroidism, in which the pituitary is pushing an underactive thyroid (NIDDK; Endocrine Society).
  • Low free T4 (FT4) together with high TSH supports overt primary hypothyroidism (JAMA Patient Page; related NICE framing).
  • Free T4 helps confirm and interpret results. NIDDK notes free T4 is preferred when binding proteins change (for example in pregnancy, oral contraceptive use, illness, or corticosteroid use).
  • Antibody tests such as TPO antibodies may support an autoimmune/Hashimoto's cause. The Endocrine Society notes anti-TPO is often present in Hashimoto's but can also be present without hypothyroidism. NICE recommends considering TPO antibodies once for adults with TSH above the reference range and not routinely repeating them.
  • Secondary (central) hypothyroidism: free T4 is low with TSH inappropriately low or normal (or rarely raised). NICE advises measuring both TSH and FT4 when pituitary disease is suspected, and in children.

NICE also advises considering testing when there is clinical suspicion; offering testing for type 1 diabetes or other autoimmune disease or new-onset atrial fibrillation; considering testing for depression or unexplained anxiety; not testing solely for type 2 diabetes; and avoiding testing during acute illness unless the illness is thought to be due to thyroid disease. Biotin supplements can falsely alter some thyroid test results. Clinicians ask about intake (NICE).

Lab ranges vary: do not treat one number as universal

The Endocrine Society states that normal TSH ranges vary by laboratory and rise with age. Pregnancy needs trimester-specific interpretation under clinician care (NIDDK; NHS). This article does not publish a DIY "normal TSH is X-Y" table. If a laboratory report shows a reference range, that range belongs to that assay and clinical context, not a universal patient rule. JAMA materials note that screening is generally not recommended for asymptomatic adults, with targeted testing for high-risk groups instead.

Subclinical Hypothyroidism: What It Means and Why Advice Differs

Definition

Subclinical hypothyroidism (SCH) means TSH is above the laboratory reference range while free T4 remains within the reference range. That definition is shared by NICE NG145, Cochrane, and a BMJ Rapid Recommendation (2019).

Guidelines disagree on routine treatment

Trusted sources do not all give the same treatment advice for adult SCH. Presenting only one side would mislead readers.

  • NICE NG145 (United Kingdom): When discussing treatment, clinicians consider features suggesting underlying thyroid disease (symptoms, prior radioactive iodine or surgery, raised autoantibodies). NICE says consider levothyroxine for adults with TSH ≥10 mIU/L on two occasions three months apart. It also says consider a six-month trial of levothyroxine for adults under 65 with TSH above the reference range but below 10 mIU/L on two occasions and symptoms, and to stop if symptoms persist once TSH is in range.
  • BMJ Rapid Recommendations (2019): A strong recommendation against thyroid hormone therapy for most adults with SCH. The recommendation does not apply to women who are pregnant or trying to conceive, or to patients with TSH >20 mIU/L. It may not apply to people with severe symptoms or young adults (for example ≤30 years). The panel concluded there is little or no clinically relevant benefit for quality of life or thyroid-related symptoms and favored monitoring instead, noting that many elevated TSH values revert and that symptoms are hard to attribute.
  • Cochrane review (2007): Across included randomized trials of levothyroxine for SCH (12 trials, 350 people), treatment did not improve survival or cardiovascular morbidity in the available evidence; quality of life and symptoms showed no significant differences versus placebo or no treatment; some lipid or echocardiographic parameters may improve; adverse effects were inadequately reported.
  • NIDDK pregnancy page: Some women with SCH may not need treatment in the pregnancy context, again a clinician judgment.

What this means for patients

SCH is a laboratory pattern, not a license to start levothyroxine at home. Guidelines disagree; decisions are clinician-led. Do not self-start thyroid hormone for "borderline labs."

When to See a Doctor: Pregnancy, Red Flags, and Emergencies

Non-urgent evaluation

The NHS advises seeing a GP if you think you might have an underactive thyroid. Persistent suggestive symptoms, especially with risk factors such as autoimmune disease, family history, recent pregnancy, or prior thyroid treatment, warrant clinical assessment rather than prolonged self-diagnosis. JAMA materials emphasize targeted testing for high-risk groups rather than routine screening of asymptomatic adults.

If care plans feel unsettled after a diagnosis or treatment discussion, some people also consider What Is a Medical Second Opinion and Why It Matters.

Pregnancy and planning pregnancy

Tell a clinician promptly if you are pregnant or planning pregnancy. NIDDK states that untreated hypothyroidism in pregnancy can harm mother and baby; thyroid medicines used for hypothyroidism are considered safe in pregnancy; contact a doctor if pregnant because the dose often needs to increase under clinical supervision. The Endocrine Society notes risks of untreated disease in pregnancy, including birth defects, stillbirth, prematurity, and lower IQ risk, and advises testing if at risk when planning pregnancy. The NHS likewise says to tell a GP if pregnant or planning a pregnancy. Pregnancy pathways are clinician-directed. This article does not provide patient dose-increase schedules.

Advertisement

Myxoedema (myxedema) coma: rare emergency

Myxoedema coma (UK spelling; myxedema in US sources) is a rare, life-threatening extreme of severe hypothyroidism, more often in older people. The NHS, NIDDK, Endocrine Society, and JAMA Patient Page all describe it as an emergency needing immediate hospital care, not home management. Seek urgent or emergency care if severe hypothyroidism is suspected in this extreme form.

Treatment Overview: Levothyroxine Replacement and Monitoring (No Dosing Tables)

First-line replacement

For primary hypothyroidism, standard first-line treatment is levothyroxine, synthetic T4 identical to the natural hormone, usually taken lifelong, with regular blood-test monitoring so TSH stays in the reference range. The clinician chooses and adjusts the dose using blood tests. People can usually live a normal life when treated (NHS; NIDDK).

NIDDK describes pills, liquid, and soft-gel forms; many people take medicine in the morning before eating as commonly recommended. Blood tests are often rechecked after starting or changing a dose, then periodically once stable. Confirm timing with your clinician (NIDDK; JAMA).

What NICE does not routinely offer

NICE NG145 advises: offer levothyroxine first-line; do not routinely offer liothyronine alone or in combination; do not offer natural thyroid extract. Aim for TSH in the reference range and avoid TSH suppression or thyrotoxicosis from overtreatment. Starting-dose figures appear in clinician guidelines; they are not reproduced here as patient self-instructions.

Risks of the wrong dose

Too little replacement leaves hypothyroidism undertreated. Too much thyroid hormone raises risks that sources link to atrial fibrillation, osteoporosis and fractures, and other heart-related harm (NHS, NIDDK, JAMA). Broader context: Symptoms of Osteoporosis: Early Signs You Should Not Ignore; Heart Arrhythmias: Symptoms, Causes, Diagnosis, and Treatment (Complete Guide). NHS examples of wrong-dose side effects include nausea, diarrhoea, headaches, and sleep problems. Take medicines as prescribed; NIDDK advises never stopping without medical advice.

Pregnancy treatment notes (high level)

In pregnancy, people usually continue and adjust levothyroxine under clinician advice. NIDDK notes that animal desiccated thyroid and high-T3 products are not appropriate in pregnancy. Some SCH in pregnancy may not need treatment. That is a clinician decision only.

This article does not include levothyroxine dosing tables, microgram-per-kilogram starters, or "start at X mcg" instructions. Dose selection and adjustment are clinical.

Living With Hypothyroidism: Follow-Up, Medicine Interactions, and Myths

Follow-up and brand consistency

Once stable, many people need periodic TSH checks. NIDDK describes yearly checks once stable as a common pattern. Confirm the schedule with your clinician. The Endocrine Society's Hashimoto page notes that the same brand is often preferred when consistency matters for an individual. Report new or returning symptoms rather than changing or stopping tablets independently.

Absorption: space certain products

Calcium, iron, and antacids can interfere with absorption of thyroid medicine. The Endocrine Society advises spacing them several hours from thyroid medicine; BMJ Rapid Recommendations materials include a similar practical note. This is high-level spacing advice, not a full interaction table. Ask a clinician or pharmacist about timing with other medicines and supplements.

Myths and unsupported "fixes"

  • Selenium for Hashimoto's: Cochrane (2013) found insufficient evidence. It is not a proven therapy.
  • "Natural" thyroid extract or routine liothyronine: NICE does not offer extract and does not routinely offer liothyronine.
  • Iodine/kelp megadoses: Deficiency is rare in the UK and US; excess can worsen autoimmune thyroid disease (NIDDK).
  • Symptom checklists or self-starting for borderline SCH: Overlap is common; blood tests and clinician judgment decide. Guidelines disagree on SCH.

Conclusion

Hypothyroidism is inadequate thyroid hormone production, often Hashimoto's in iodine-sufficient countries and iodine deficiency worldwide. Symptoms do not replace blood tests; SCH treatment is clinician-led. Seek care for persistent symptoms, pregnancy, or suspected myxoedema (myxedema) coma. Standard care is clinician-adjusted levothyroxine, not dosing tables or unproven self-remedies.

Medical Disclaimer

Content on MED.COM is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with questions about a medical condition. Never disregard professional medical advice or delay seeking it because of something read on this site. If you think you may have a medical emergency, contact local emergency services immediately.

Sources & References

  1. 1.
    Hypothyroidism (Underactive Thyroid)

    National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) • Mar 1, 2021

  2. 2.
    Thyroid Tests

    National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) • May 1, 2017

  3. 3.
    Thyroid Disease & Pregnancy

    National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) • Dec 1, 2017

  4. 4.
    Underactive thyroid (hypothyroidism)

    NHS • Apr 28, 2025

  5. 5.
    Thyroid disease: assessment and management (NG145) - Recommendations

    NICE • Nov 1, 2019

  6. 6.
    Hashimoto Disease

    Endocrine Society • Jan 24, 2022

  7. 7.
    Thyroid and Parathyroid Hormones

    Endocrine Society • Jan 24, 2022

  8. 8.
    Thyroid hormone replacement for subclinical hypothyroidism

    Cochrane • Jul 18, 2007

  9. 9.
    Selenium supplementation for Hashimoto's thyroiditis

    Cochrane • Jun 6, 2013

  10. 10.
    Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline

    The BMJ • May 14, 2019

  11. 11.
    What Is Hypothyroidism? (JAMA Patient Page)

    JAMA • Dec 11, 2025

  12. 12.
    Hypothyroidism: A Review

    JAMA • Sep 3, 2025

Focus Areas

HypothyroidismUnderactive ThyroidHashimoto's DiseaseTSHLevothyroxineSubclinical HypothyroidismEndocrinologyThyroid Hormones

Stay informed with the latest medical insights from MED.COM

Advertisement

Related Articles

metabolic health

Type 1 vs Type 2 Diabetes: Understanding the Key Differences

6 minApr 30, 2026

metabolic health

Insulin Resistance: What It Is and Why It Matters

8 minApr 30, 2026

metabolic health

When Should You See an Endocrinologist for Diabetes?

6 minApr 30, 2026
MedCom

MED.COM is a curated medical knowledge platform.

Our content is designed to support understanding of medical fields, conditions, and developments — with clarity and professional standards.

contact@med.com

Health

Platform

  • Medical Topics
  • About

Legal

  • Privacy Policy
  • Terms of Use
  • Accessibility
© 2026 MED.COM. All rights reserved.
Opt out of the sale or sharing of personal information

Opt out of the sale or sharing of personal information

We won't sell or share your personal information to inform the ads you see. You may still see interest-based ads if your information is sold or shared by other companies or was sold or shared previously.